Calibrating your scientific data strategy applying FAIR principles in the cloud
Sponsored by TetraScience and AWS
A new research survey of 500 biopharma executives, commissioned by TetraScience and AWS, reveals why life sciences companies need to rethink their data platforms. Replatforming scientific data to an open cloud platform while transforming the data to FAIR (Findable, Accessible, Interoperable, Reusable) principles significantly impacts three key industry drivers:
o Speed: Learning from experiments faster, reducing time to market for final molecules.
o Cost: Improving productivity, increasing operational efficiency, increasing return on investment (ROI).
o Risk: Improving safety, reducing errors, improving compliance with regulatory requirements
The speakers will also share insights and updates from the Bio-IT World Conference. Whether you’re just getting started or are developing the next phases of your replatforming strategy, this webinar will provide you with essential information and key insights.
Learning Objectives:
● Competitive advantages to developing a scientific data cloud strategy
● Best approaches to getting started with replatformed scientific data in the cloud
● Long-term advantages, including moving into ML, AI, and advanced analytics
Privacy Policy
In his current role, Chad partners with TetraScience customers, utilizing his deep enterprise experience and acting as a guide for digital transformation. Chad currently advises TetraScience’s customers who include the top 14 of 25 biopharmaceutical companies globally.
He has provided value across Life Sciences value chain across Drug Discovery, Pre-Clinical, clinical phases(I-IV) PV (Pharmacovigilance) , Commercial Excellence and Portfolio due diligence, Patient Support Programs and Real-World Data Analytics through consulting services, innovation transformation, revenue growth, thought leadership, strategic planning, strategic alliances and business case positioning, product development, solutions road mapping, program management, data governance and technology strategy/implementation for global life sciences pharma customers. He also possesses similar experiences in driving Commercial Transformation through Sales Force Alignment, Targeting, Launch Strategy, Patient Adherence, Segmentation and Digital/Mobility transformation.
